Polymyositis, Pulmonary Fibrosis and Autoantibodies to Aminoacyl-tRNA Synthetase Enzymes, QJM, vol.77, issue.1, pp.1019-1038, 1990. ,
DOI : 10.1093/qjmed/77.1.1019
Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome, Respiratory Medicine, vol.106, issue.4, pp.581-587, 2012. ,
DOI : 10.1016/j.rmed.2012.01.001
Interstitial Lung Disease in Anti-Jo-1 Patients With Antisynthetase Syndrome, Arthritis Care & Research, vol.37, issue.Suppl, pp.800-808 ,
DOI : 10.1002/acr.21895
Antisynthetase Syndrome, Current Rheumatology Reports, vol.65, issue.7, pp.175-181, 2011. ,
DOI : 10.1007/s11926-011-0176-8
A New Approach to the Classification of Idiopathic Inflammatory Myopathy, Medicine, vol.70, issue.6, pp.360-374, 1991. ,
DOI : 10.1097/00005792-199111000-00002
The long-term outcome of anti-Jo-1-positive inflammatory myopathies, J Neurol, vol.251, pp.859-864, 2004. ,
Polymyositis and Dermatomyositis, New England Journal of Medicine, vol.292, issue.7, pp.344-347, 1975. ,
DOI : 10.1056/NEJM197502132920706
Polymyositis and Dermatomyositis, New England Journal of Medicine, vol.292, issue.8, pp.403-407, 1975. ,
DOI : 10.1056/NEJM197502202920807
O97 Polymyositis and dermatomyositis: short-term and long-term outcome, and predictive factors of prognosis, European Journal of Internal Medicine, vol.14, pp.2230-2237, 2001. ,
DOI : 10.1016/S0953-6205(03)91246-5
Clinical respiratory physiology: standardized lung function testing: working party report: standardization of lung function tests, Bull Eur Physiopathol Respir, vol.19, pp.1-95, 1983. ,
Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: A series of 107 patients, Arthritis & Rheumatism, vol.41, issue.Suppl 5, pp.3439-3447, 2011. ,
DOI : 10.1002/art.30513
A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis, Arthritis & Rheumatism, vol.4, issue.9, pp.1218-1224, 1995. ,
DOI : 10.1002/art.1780380907
Long-Term Survival of Patients With Idiopathic Inflammatory Myopathies According to Clinical Features, Medicine, vol.83, issue.1, pp.35-42, 2004. ,
DOI : 10.1097/01.md.0000109755.65914.5e
Polymyositis - treatment and prognosis, Acta Neurologica Scandinavica, vol.263, issue.4, pp.280-300, 1982. ,
DOI : 10.1111/j.1600-0404.1982.tb03087.x
Mortality from polymyositis and dermatomyositis in the united states, 1968???1978, Arthritis & Rheumatism, vol.14, issue.12, pp.1465-1471, 1968. ,
DOI : 10.1002/art.1780261208
Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients., Annals of the Rheumatic Diseases, vol.52, issue.12, pp.857-861, 1993. ,
DOI : 10.1136/ard.52.12.857
Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality, Rheumatology, vol.41, issue.1, pp.22-26, 2002. ,
DOI : 10.1093/rheumatology/41.1.22
Distinctive features of idiopathic inflammatory myopathies inFrench Canadians, Seminars in Arthritis and Rheumatism, vol.26, issue.1, pp.447-458, 1996. ,
DOI : 10.1016/S0049-0172(96)80025-4
Longterm Survival and Associated Risk Factors in Patients with Adult-onset Idiopathic Inflammatory Myopathies and Amyopathic Dermatomyositis: Experience in a Single Institute in Japan, The Journal of Rheumatology, vol.38, issue.8, pp.1636-1643, 2011. ,
DOI : 10.3899/jrheum.101002
Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy, The American Journal of Medicine, vol.94, issue.4, pp.379-387, 1993. ,
DOI : 10.1016/0002-9343(93)90148-I
Therapy of polymyositis and dermatomyositis, Autoimmunity Reviews, vol.11, issue.1, pp.6-13, 2011. ,
DOI : 10.1016/j.autrev.2011.06.007
Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis, Rheumatology, vol.44, issue.1, pp.83-88, 2005. ,
DOI : 10.1093/rheumatology/keh404
Oddis CV: Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients, Ann Rheum Dis. in press, pp.10-1136 ,
Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine, Arthritis Research & Therapy, vol.14, issue.1, p.22, 2012. ,
DOI : 10.1002/art.24904
Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: A series of 73 patients, Arthritis Care & Research, vol.10, issue.12, pp.1748-1755, 2010. ,
DOI : 10.1002/acr.20325
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial, Arthritis & Rheumatism, vol.59, issue.2, pp.314-324, 2013. ,
DOI : 10.1002/art.37754
Influence of Age on Characteristics of Polymyositis and Dermatomyositis in Adults, Medicine, vol.78, issue.3, pp.139-147, 1999. ,
DOI : 10.1097/00005792-199905000-00001
Incidence of Malignant Disease in Biopsy-Proven Inflammatory Myopathy: A Population-Based Cohort Study, Annals of Internal Medicine, vol.134, issue.12, pp.1087-1095, 2001. ,
DOI : 10.7326/0003-4819-134-12-200106190-00008
Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome, J Rheumatol, vol.35, pp.169-171, 2008. ,
Malignancy in the Setting of the Anti-Synthetase Syndrome, JCR: Journal of Clinical Rheumatology, vol.14, issue.5, pp.285-288, 2008. ,
DOI : 10.1097/RHU.0b013e31817d116f
Survival analysis of patients with dermatomyositis and polymyositis, Clinical Rheumatology, vol.12, issue.12, pp.1595-1601, 2011. ,
DOI : 10.1007/s10067-011-1840-0
Survival, mortality and causes of death in inflammatory myopathies, Autoimmunity, vol.125, issue.3, pp.205-215, 2006. ,
DOI : 10.1016/0049-0172(86)90014-4
Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody, British Journal of Dermatology, vol.141, issue.2, pp.337-344, 2010. ,
DOI : 10.1111/j.1365-2133.2009.09484.x